Propanc Biopharma names Carlo Campiciano to board after Van Broekhoven retirement

PPCB•2026-07-14

Board change effective July 8, 2026

Propanc Biopharma reported a board change effective July 8, 2026, with director Annie Van Broekhoven retiring and stepping down.

The board appointed Carlo Campiciano to fill the vacancy, serving until resignation or removal.

Campiciano is a qualified accountant, previously CFO and company secretary at ASX-listed MedAdvisor, helping lead capital raises and the 2015 listing.

Sources

Propanc Biopharma names Carlo Campiciano to board after Van Broekhoven retirement

Sec

Propanc Biopharma names Carlo Campiciano to board after Van Broekhoven retirement

Board change effective July 8, 2026

Related News

Kongsberg And Oceaneering Selected For U.S. Defense Innovation Unit Camp Program

Coinbase Global Inc moved ACX order books to limit-only mode and will suspend trading of ACX on July 28, 2026

Lionsgate Studios attracts takeover interest from Bollore, Banijay, sources say

Sources

Propanc Biopharma names Carlo Campiciano to board after Van Broekhoven retirement

SBC Medical Group stockholders adopt amended charter opting out of DGCL Section 203

Viking Therapeutics posts corporate presentation highlighting VK2735 obesity drug program pipeline